Primary pulmonary small cell carcinoma in a 13-year-old boy with prolonged second-hand tobacco smoke exposure: A rare pediatric lung malignancy with a review of reported cases and registry data.
6 affiliations
- 1Children Growth Disorder Research Center, Comprehensive Research Institute for Maternal and Child Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- 2Mother and Newborn Health Research Center, Comprehensive Research Institute for Maternal and Child Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- 3Student Research Committee, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- 4Hematology and Oncology Research Center, Non-Communicable Diseases Research Institute, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
- 5Department of Pathology, Shahid Sadoghi University of Medical Sciences, Yazd, Iran.
- 6Department of Internal Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Abstract
Background
Primary pulmonary small cell carcinoma (PPSCC) is an exceptionally rare, highly aggressive neuroendocrine carcinoma in the pediatric population, with only a handful of cases reported worldwide. Its rarity, nonspecific clinical presentation, and limited published experience often delay diagnosis and leave important questions regarding its clinicopathological characteristics and potential risk factors unanswered.Case presentation
A 13-year-old boy presented with a four-month history of persistent cough, progressive dyspnea, recurrent lower respiratory tract infections, and significant unintentional weight loss despite treatment for presumed asthma and pneumonia. Shortly before admission, he developed right parasternal chest pain. He had no history of active smoking; however, he had a prolonged history of exposure to environmental tobacco smoke at home (heavy paternal smoking). Contrast-enhanced chest computed tomography revealed a large right hilar mass with mediastinal extension, bronchial obstruction, and metastatic involvement of the liver and abdominal lymph nodes. Bronchoscopic biopsy followed by immunohistochemical analysis (AE1/AE3+, CD56⁺, TTF-1+, CD45⁻, LCA-) confirmed the diagnosis of primary pulmonary small cell carcinoma. Given the advanced stage of disease, systemic platinum-based chemotherapy was initiated. To provide broader clinical context, we additionally reviewed previously reported pediatric cases of PPSCC and available registry data, focusing on demographic characteristics, presenting features, diagnostic approaches, treatment strategies, and outcomes.Conclusion
This case emphasizes that PPSCC, although exceptionally uncommon, should be considered in children and adolescents with persistent respiratory symptoms, unexplained weight loss, or non-resolving pulmonary infiltrates despite appropriate treatment. Early cross-sectional imaging followed by timely tissue diagnosis is essential to avoid diagnostic delay.
Related
- Incidental pulmonary nodules detected on computed tomography pulmonary angiography: prevalence and malignancy outcomes from a Thai tertiary-care center
- Disseminated Pulmonary Coccidioidomycosis Presenting as a Wedge-Shaped Necrotic Mass Mimicking Malignancy
- 455 Second primary malignancy risk in the immunotherapy era among urothelial carcinoma survivors: a SEER population-based analysis
- Pulmonary thromboembolism with prolonged pulmonary infarction during intensive decongestion for severe heart failure : A case report
- Pulmonary epithelioid hemangioendothelioma with pleural dissemination: a case report of prolonged diagnostic delay and the role of surgical biopsy.
BibTeX
@article{modarresi2026primary,
title = {{Primary pulmonary small cell carcinoma in a 13-year-old boy with prolonged second-hand tobacco smoke exposure: A rare pediatric lung malignancy with a review of reported cases and registry data.}},
author = {Seyedeh Zalfa Modarresi and Mahla Towhidifar and Somayeh Talaeipour and Maryamsadat Yazdanparast and Fariba Binesh and FatemehalSadat AghaeiMeybodi},
journal = {Respiratory medicine case reports},
year = {2026},
month = oct,
doi = {10.1016/j.rmcr.2026.102533},
url = {https://europepmc.org/article/MED/42960200},
note = {CC BY},
}
RIS
TY - JOUR
TI - Primary pulmonary small cell carcinoma in a 13-year-old boy with prolonged second-hand tobacco smoke exposure: A rare pediatric lung malignancy with a review of reported cases and registry data.
AU - Seyedeh Zalfa Modarresi
AU - Mahla Towhidifar
AU - Somayeh Talaeipour
AU - Maryamsadat Yazdanparast
AU - Fariba Binesh
AU - FatemehalSadat AghaeiMeybodi
PY - 2026
DA - 2026/10/19
JO - Respiratory medicine case reports
DO - 10.1016/j.rmcr.2026.102533
UR - https://europepmc.org/article/MED/42960200
AB - Background Primary pulmonary small cell carcinoma (PPSCC) is an exceptionally rare, highly aggressive neuroendocrine carcinoma in the pediatric population, with only a handful of cases reported worldwide. Its rarity, nonspecific clinical presentation, and limited published experience often delay diagnosis and leave important questions regarding its clinicopathological characteristics and potential risk factors unanswered.Case presentation A 13-year-old boy presented with a four-month history of persistent cough, progressive dyspnea, recurrent lower respiratory tract infections, and significant unintentional weight loss despite treatment for presumed asthma and pneumonia. Shortly before admission, he developed right parasternal chest pain. He had no history of active smoking; however, he had a prolonged history of exposure to environmental tobacco smoke at home (heavy paternal smoking). Contrast-enhanced chest computed tomography revealed a large right hilar mass with mediastinal extension, bronchial obstruction, and metastatic involvement of the liver and abdominal lymph nodes. Bronchoscopic biopsy followed by immunohistochemical analysis (AE1/AE3+, CD56⁺, TTF-1+, CD45⁻, LCA-) confirmed the diagnosis of primary pulmonary small cell carcinoma. Given the advanced stage of disease, systemic platinum-based chemotherapy was initiated. To provide broader clinical context, we additionally reviewed previously reported pediatric cases of PPSCC and available registry data, focusing on demographic characteristics, presenting features, diagnostic approaches, treatment strategies, and outcomes.Conclusion This case emphasizes that PPSCC, although exceptionally uncommon, should be considered in children and adolescents with persistent respiratory symptoms, unexplained weight loss, or non-resolving pulmonary infiltrates despite appropriate treatment. Early cross-sectional imaging followed by timely tissue diagnosis is essential to avoid diagnostic delay.
SN - 2213-0071
ER -